AJPB® Translating Evidence-Based Research Into Value-Based Decisions®

AJPB® The American Journal of Pharmacy Benefits® November 2024
Advertisement
Advertisement
Trending on Pharmacy Times
1
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
2
Dexmedetomidine Receives FDA Approval for Acute Treatment for Agitation Associated With Schizophrenia
3
Blood Glucose Testing: When Nonadherence Isn't the Real Issue
4
FDA Approves Gefurulimab as First Once-Weekly, Self-Administered C5 Inhibitor for gMG
5
